Discover how advanced genomic testing identifies targeted therapies, informs clinical decisions, and transforms patient outcomes in modern oncology.
Multi-gene panel sequencing to identify actionable mutations across solid tumours and haematological malignancies.
Correlate molecular signatures with approved targeted therapies and active clinical trial eligibility criteria.
Non-invasive circulating tumour DNA profiling for real-time monitoring of tumour evolution and treatment response.
Genomic testing fundamentals — how NGS panels decode tumour biology to guide oncologic decision-making.
Targeted therapy selection — matching molecular alterations to approved agents and emerging treatments.
Clinical trial access — navigating eligibility criteria and maximising trial enrolment for optimal outcomes.
Personalized care pathways — integrating genomic data into holistic, patient-centered oncology workflows.
Join clinicians, researchers, and healthcare professionals for this exclusive seminar. Limited seats available — early registration is strongly encouraged.